Cholesterol transport protein emerges as possible target for Parkinson's treatment
Parkinson's disease (PD) is a neurodegenerative condition that causes the progressive loss of dopamine-producing neurons in a brain region called the substantia nigra. Its characteristic symptoms include tremors, slowed movements, rigid muscles and difficulties with balance.
Read original article on Medical Xpress - latest medical and health news stories →Related news
-
An intact primary visual cortex is necessary for conscious position perception, study finds
United Kingdom
-
Menopause can quietly weaken bones—here's what research reveals about protecting them
United Kingdom
-
Targeted scan detects hidden multiple myeloma missed by standard imaging
United Kingdom
-
New study of Medicare 'ExRad' quality measure data shows wide variations in CT scan radiation dose
United Kingdom
-
A doctor's take: When the diagnosis isn't right: What you need to know about misdiagnosis
United Kingdom
-
Earlier bedtime linked to greater weight loss in prediabetes trial
United Kingdom
-
What if we stop treating social care like a service? This village shows the way
United Kingdom
-
Tragic water-related deaths drain billions from the UK economy
United Kingdom